1339: Dividend Approvals And Updated Forecasts Will Guide Fair Valuation Ahead

Analysts have raised their price target for People's Insurance Company (Group) of China from ¥6.76 to ¥7.17. This change reflects updated expectations for key financial metrics and overall performance.

The analyst price target for People's Insurance Company (Group) of China has been revised downward by analysts, decreasing from ¥6.85 to ¥6.76. This reflects more cautious expectations around revenue growth and future earnings valuations.

The slight upward revision in the price target for People's Insurance Company (Group) of China is primarily driven by a modest increase in consensus revenue growth forecasts, with fair value rising from HK$6.68 to HK$6.85. What's in the News Proposed interim dividend of RMB 0.075 per share for the first half of 2025, payable on 16 January 2026.

Despite a downgrade in revenue growth forecasts, a notable increase in net profit margin has driven the consensus analyst price target for People's Insurance Company (Group) of China up from HK$6.13 to HK$6.68. What's in the News Proposed ordinary interim dividend of RMB 0.075 per share for the six months ended 30 June 2025, payable on 16 January 2026.

Despite a notable downgrade in consensus revenue growth forecasts, a significant improvement in net profit margin has driven the consensus analyst price target for People's Insurance Company (Group) of China higher, rising from HK$5.76 to HK$6.13. What's in the News Board meeting scheduled to consider interim results for H1 2025 and potential interim dividend.

Improved net profit margin and a marginally higher Future P/E multiple have contributed to a higher consensus analyst price target, which has increased from HK$5.33 to HK$5.76. What's in the News Shareholders approved amendments to the Articles of Association at the AGM; changes will take effect upon NFRA approval, with the existing version remaining in place until then.

The consensus analyst price target for People's Insurance Company (Group) of China has increased, reflecting a notably higher future P/E ratio despite a modest decline in net profit margin, with fair value revised upward from HK$5.06 to HK$5.33. What's in the News Amendments to the Articles of Association were approved at the AGM, pending effectiveness upon NFRA approval.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.